🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congrats Melvin LK CHUA | FRCR, PhD, FASCO!

V. Honoured to be mentioned along with giants in the field of #Oncology Mary Gospodarowicz Rebecca Dent Many thanks to ASCO Eric J. Small, MD, FASCO for the opportunities to volunteer and connect with the #Global cancer community 😊😊 #FASCO #Volunteer

5 remarkable things: - Melvin LK CHUA | FRCR, PhD, FASCO - superb mentor and clinician-scientist ✊🏼 - Boon - superb trainee 💪🏼 - Genomic Classifier Decipher by Veracyte 🧬 - Best poster at #ESMOAsia24 🇸🇬 - Focal therapy for prostate cancer 🧐 Just one that causes more harm than good - take your guess 🤪

#ESMOASIA2024 Super proud to see Dr Hong Boon Hao from #chualabnccs getting the Best Poster award for his work on Decipher biomarker for predicting failures post-FT in #ProstateCancer Thanks for amazing collaborators Kae Jack Tay Alejandro (Ale) Berlin Elai Davicioni Decipher by Veracyte

💔😞 RIP, my friend Felix Feng Please consider donating to the American Cancer Society ASTRO Felix Feng MD Clinician Scientist Grant Award. Let his incredible legacy live on. donate.cancer.org/g/tjjfqwdnrxrl…

Good luck if you need fly with LATAM Chile (you’ll need it!)… if you need them to respond to luggage-related issues their service is the most dismissive and unpleasant experience. Suggest you consider SKY, more customer-oriented.

🚀We're proud to celebrate the incredible work of our team! At Cancer Digital Intelligence, we're dedicated to driving change and using cutting edge solutions to re-define patient-centered care!

A monumental work to start 2025! JCI insight Led by Jinxin BEI and global team 🇭🇰🇨🇳🇸🇬 We uncovered the link between germline SNPs & TIME of #NPC #nasopharyngealcarcinoma - RPL14 that modulates the EBV life cycle - SELE that modulates the TIME jci.org/articles/view/…

Announcing NRG-CC014 (PREEMPT) by Dr. Gillespie! 📢 A Phase 3 trial exploring radiation therapy for high-risk asymptomatic bone metastases. A step forward in innovative cancer care! Erin Gillespie, MD MPH #radonc NRG Oncology RTOG Foundation #NRG2025

Great to see so many friends and colleagues committed to innovative and practice-changing clinical trials at NRG Oncology in Phoenix. 2025 will be a big year for bladder preservation with NRG launching 2 randomized trials looking at adaptive (20 vs 5 fractions) chemoRT in MIBC

Prostate cancer case. Dr. Andrew Loblaw Vedang Murthy Daniel E Spratt Alejandro (Ale) Berlin @ 57-year-old healthy man. PSA 14.3 Digital exam no nodules MR PI-RADS 5 no lymph nodes, ISUP 3 PET PSMA Nonspecific external lymph node Nodal risk: 20%. Would you treat pelvic lymph nodes?

Congrats on this important work! Elai Davicioni From our early work to predict DM in IGRT treated patients to now predicting RT dose response - We may have a biomarker for #precisionradiotherapy in #prostatecancer! Alan Dal Pra, MD Alejandro (Ale) Berlin Shankar Siva

Toronto’s University Health Network launches recruitment campaign for scientists theglobeandmail.com/canada/article…

My family was burglarized while sleeping in an Airbnb, > $21K USD in valuables stolen Promised security and “AirCover”? We got nothing They've ignored claim, deleted my review, burying the truth Arbitration coming, Brian Chesky-fix this! #AirbnbNightmare #AirbnbFail #AirbnbScam

Such a pleasure to speak to such an esteemed department! Thank you for having me.

Full version of GU Pathology Society (GUPS) GUPS and International Society of Urological Pathology ISUP white paper on defining indolent #prostatecancer is now available. An excellent product of the outstanding collaboration between the #GUPath societies. Congratulations to all! pubmed.ncbi.nlm.nih.gov/40444986/ 👇👇👇

If you spoke out about civilian deaths in Gaza but are silent on Iran’s indiscriminate attacks targeting civilians, ask yourself: was it really about human life -or something else? Selective outrage isn't virtue. If it's rooted in hate, own it. Don’t hide behind false narratives

The current epidemic of (North American?) academic medicine… saddening.

We just received ethics approval for our new SPRINT trial! SPRINT is for patients who've had a parotidectomy for cutaneous SCC metastatic to parotid/neck nodes, testing 5-fraction SABR vs. standard 4-6 weeks of RT. We're always looking for interested centres to join us!

#SABR2025 registrations are open #radonc!! sabrsymposium.com - Come join us Peter Mac Cancer Centre Peter Mac Radiation Oncology on Nov 14th-15th. We have a phenomenal international faculty line up 🇺🇸🇨🇦🇮🇹🇫🇷🇦🇺with Pierre Blanchard, MD Lauren Henke, MD, MSCI, prof. Barbara Jereczek-Fossa, Drew Moghanaki and Melissa O'Neil MRT(T).